Home / Promethazine / United States
US ATC D04AA10 · updated 2 Nov 2026
Promethazine shortage in United States
Is there a Promethazine shortage in United States?
Yes. As of 2 Nov 2026, 10 Promethazine products are reported short in United States, the first since 21 Nov 2023. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25) | Hikma Pharmaceuticals USA, Inc. | 21 Nov 2023 | not given | Not stated |
| US | Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25) | Hikma Pharmaceuticals USA, Inc. | 21 Nov 2023 | not given | Other |
| US | Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25) | Hikma Pharmaceuticals USA, Inc. | 21 Nov 2023 | not given | Not stated |
| US | Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25) | Hikma Pharmaceuticals USA, Inc. | 21 Nov 2023 | not given | Other |
| US | Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25) | Hikma Pharmaceuticals USA, Inc. | 21 Nov 2023 | not given | Not stated |
| US | Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35) | Hikma Pharmaceuticals USA, Inc. | 21 Nov 2023 | not given | Increased demand Demand increase for the drug |
| US | Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3) | XGen Pharmaceuticals DJB, Inc. | 21 Nov 2023 | not given | Not stated |
| US | Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25) | Hikma Pharmaceuticals USA, Inc. | 21 Nov 2023 | not given | Increased demand Demand increase for the drug |
| US | Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35) | Hikma Pharmaceuticals USA, Inc. | 21 Nov 2023 | not given | Not stated |
| US | Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6) | XGen Pharmaceuticals DJB, Inc. | 21 Nov 2023 | not given | Increased demand Demand increase for the drug |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).